CRISPR Therapeutics CEO talks winning FDA approval for sickle cell anemia treatment

Uploaded By: Myvideo

Published on

1 Feb 2024

1 view

0

0 votes

0

About Share Download Add to

Samarth Kulkarni, CRISPR Therapeutics CEO, joins ’Closing Bell Overtime’ to talk winning FDA approval in the U.S. for sickle cell treatment in partnership with Vertex.

Share with your friends

Link:

Embed:

<iframe width="640" height="360" src="//myvideo.cc/embed/K2s2NjVJMUptQ2xxMFpWOVRWaFdFQVhDV2lhZXBLVk91bWZ5TXp0d3Y3bz0" frameborder="0" webkitallowfullscreen mozallowfullscreen allowfullscreen></iframe>

Video Size:

Custom size:

x

Autoplay video

Hide player controls

Hide resume playing

Add to Playlist:

Favorites

My Playlist

Watch Later

Журнальный клуб НЦН 25 сентября 2024 г.

5 months ago

00:39:17

Журнальный клуб НЦН 25 сентября 2024 г.

18 87%

FDA approves gene-editing therapy for sickle cell disease

1 year ago

00:07:16

FDA approves gene-editing therapy for sickle cell disease

1 43%

CRISPR Therapeutics CEO talks winning FDA approval for sickle cell anemia treatment

1 year ago

00:05:27

CRISPR Therapeutics CEO talks winning FDA approval for sickle cell anemia treatment

1 9%

( )

1 year ago

00:00:04

( )

1 41%

Inmode (INMD) Stock Analysis Update | Most Undervalued Stocks Right Now

4 years ago

00:12:39

Inmode (INMD) Stock Analysis Update | Most Undervalued Stocks Right Now

1 32%

Futurology

4 years ago

00:08:35

Futurology

1 32%

0 Comments

Guest